GPT Healthcare Limited (GPTHEALTH.NS)
- Previous Close
151.61 - Open
152.50 - Bid 151.60 x --
- Ask 151.81 x --
- Day's Range
151.00 - 153.20 - 52 Week Range
126.10 - 208.45 - Volume
128,691 - Avg. Volume
156,283 - Market Cap (intraday)
12.481B - Beta (5Y Monthly) --
- PE Ratio (TTM)
24.94 - EPS (TTM)
6.08 - Earnings Date May 23, 2025
- Forward Dividend & Yield 2.50 (1.65%)
- Ex-Dividend Date Jul 29, 2025
- 1y Target Est
163.00
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the name ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; emergency and critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurosciences; pediatrics; neonatology; robotic procedures; bariatric and metabolic surgery; minimally invasive gyanecological surgery; and urology. It also operates clinics and pharmacies, as well as provides academic and diagnostic services, and sale of power. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.
ilshospitals.comRecent News: GPTHEALTH.NS
View MorePerformance Overview: GPTHEALTH.NS
Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GPTHEALTH.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GPTHEALTH.NS
View MoreValuation Measures
Market Cap
12.44B
Enterprise Value
12.37B
Trailing P/E
24.94
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.06
Price/Book (mrq)
5.02
Enterprise Value/Revenue
3.04
Enterprise Value/EBITDA
13.46
Financial Highlights
Profitability and Income Statement
Profit Margin
12.26%
Return on Assets (ttm)
11.02%
Return on Equity (ttm)
21.41%
Revenue (ttm)
4.07B
Net Income Avi to Common (ttm)
499.22M
Diluted EPS (ttm)
6.08
Balance Sheet and Cash Flow
Total Cash (mrq)
362.51M
Total Debt/Equity (mrq)
14.24%
Levered Free Cash Flow (ttm)
217.3M